Name | AZD4320 |
Synonyms | AZD4320 Benzamide, 4-[4-[(R)-(4'-chloro[1,1'-biphenyl]-2-yl)hydroxymethyl]-1-piperidinyl]-N-[[4-[[(1R)-3-[(2-hydroxyethyl)methylamino]-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]- |
CAS | 1357576-48-7 |
Molecular Formula | C45H48ClF3N4O7S3 |
Molar Mass | 945.53 |
Density | 1.46±0.1 g/cm3(Predicted) |
Solubility | DMSO : 125 mg/mL (132.20 mM; Need ultrasonic) |
pKa | 4.70±0.10(Predicted) |
Storage Condition | -20℃ |
Target | BCL2 BCLxL |
Reference Show more | 1. Takimoto-Shimomura T, et al. Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2. Invest New Drugs. 2018 Jun 21. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.058 ml | 5.288 ml | 10.576 ml |
5 mM | 0.212 ml | 1.058 ml | 2.115 ml |
10 mM | 0.106 ml | 0.529 ml | 1.058 ml |
5 mM | 0.021 ml | 0.106 ml | 0.212 ml |